Римантадин (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Римантадин" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

3freepatentsonline.com

5,449^th place

9,087^th place

3doi.org

2^nd place

4^th place

3nih.gov

4^th place

5^th place

2google.com

163^rd place

148^th place

2web.archive.org

1^st place

1compendium.com.ua

low place

238^th place

1influenza.spb.ru

low place

1worldcat.org

5^th place

9^th place

1semanticscholar.org

11^th place

964^th place

1who.int

195^th place

71^st place

1mashkovsky.ru

low place

1,152^nd place

1fda.gov

447^th place

906^th place

compendium.com.ua

РИМАНТАДИН (RIMANTADINUM) Опис активної речовини

doi.org

Zlydnikov DM, Kubar OI, Kovaleva TP, Kamforin LE (1981). Study of rimantadine in the USSR: a review of the literature. Reviews of Infectious Diseases. 3 (3): 408—21. doi:10.1093/clinids/3.3.408. PMID 7025146.
Vorobjev YN (April 2020). An effective molecular blocker of ion channel of M2 protein as anti-influenza A drug. Journal of Biomolecular Structure and Dynamics. 39 (7): 2352—2363. doi:10.1080/07391102.2020.1747550. ISSN 0739-1102. PMID 32212957. S2CID 214681984.
Zimmerman RK (March 2007). Rationing of influenza vaccine during a pandemic: ethical analyses. Vaccine. 25 (11): 2019—26. doi:10.1016/j.vaccine.2006.11.045. PMID 17258359.

fda.gov

fda.gov. Food and Drug Administration. Архів оригіналу за 30 червня 2005. Процитовано 5 листопада 2008.

freepatentsonline.com

US patent 3352912 to W. W. Prichard
United States Patent № 4551552: Process for preparing rimantadine: Rimantadine and related compounds useful as antivirals were first described by Prichard in U.S. Pat. Nos. 3,352,912 and 3,592,934. Both patents describe the preparation of rimantadine from the corresponding ketone oxime by reduction with lithium aluminum hydride.
United States Patent № 4551552: Process for preparing rimantadine

google.com

W. W. Prichard; 1963, U.S. Patent 3 352 912
Janis Polis, 1969, U.S. Patent 3 852 352

influenza.spb.ru

Main achievements of the lab in the development of new antivirals^{[недоступне посилання з квітня 2019]} (англ.)

mashkovsky.ru

" "Ремантадин в Справочнике Машковского".^{[недоступне посилання з липня 2019]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Zlydnikov DM, Kubar OI, Kovaleva TP, Kamforin LE (1981). Study of rimantadine in the USSR: a review of the literature. Reviews of Infectious Diseases. 3 (3): 408—21. doi:10.1093/clinids/3.3.408. PMID 7025146.
Vorobjev YN (April 2020). An effective molecular blocker of ion channel of M2 protein as anti-influenza A drug. Journal of Biomolecular Structure and Dynamics. 39 (7): 2352—2363. doi:10.1080/07391102.2020.1747550. ISSN 0739-1102. PMID 32212957. S2CID 214681984.
Zimmerman RK (March 2007). Rationing of influenza vaccine during a pandemic: ethical analyses. Vaccine. 25 (11): 2019—26. doi:10.1016/j.vaccine.2006.11.045. PMID 17258359.

semanticscholar.org

api.semanticscholar.org

Vorobjev YN (April 2020). An effective molecular blocker of ion channel of M2 protein as anti-influenza A drug. Journal of Biomolecular Structure and Dynamics. 39 (7): 2352—2363. doi:10.1080/07391102.2020.1747550. ISSN 0739-1102. PMID 32212957. S2CID 214681984.

web.archive.org

Influenza (Seasonal). Fact sheet N°211. March 2014. http://www.who.int/mediacentre/factsheets/fs211/en/ [Архівовано 30 листопада 2014 у Wayback Machine.]
fda.gov. Food and Drug Administration. Архів оригіналу за 30 червня 2005. Процитовано 5 листопада 2008.

who.int

Influenza (Seasonal). Fact sheet N°211. March 2014. http://www.who.int/mediacentre/factsheets/fs211/en/ [Архівовано 30 листопада 2014 у Wayback Machine.]

worldcat.org

search.worldcat.org

Vorobjev YN (April 2020). An effective molecular blocker of ion channel of M2 protein as anti-influenza A drug. Journal of Biomolecular Structure and Dynamics. 39 (7): 2352—2363. doi:10.1080/07391102.2020.1747550. ISSN 0739-1102. PMID 32212957. S2CID 214681984.